T0	Participants 75 116	patients with non-erosive reflux disease.
T1	Participants 164 193	patients with reflux symptoms
T2	Participants 342 383	patients with non-erosive reflux disease.
T3	Participants 397 408	multicentre
T4	Participants 550 710	Adults with a history of reflux symptoms, a negative endoscopy, and > or = 3 days of moderate to very severe heartburn in the 7 days before enrollment (N = 535)
T5	Participants 793 864	Patients with complete symptom relief then entered the on-demand phase.
T6	Participants 1489 1525	non-erosive reflux disease patients.